AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.230
-0.080 (-3.46%)
Mar 31, 2025, 1:37 PM EDT - Market open

AbCellera Biologics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Revenue
28.8338.03485.42375.2233.16
Upgrade
Revenue Growth (YoY)
-24.17%-92.17%29.38%60.92%1907.88%
Upgrade
Cost of Revenue
167.26175.66174.32107.5856.54
Upgrade
Gross Profit
-138.43-137.63311.11267.63176.62
Upgrade
Selling, General & Admin
85.4975.1866.7648.7615.75
Upgrade
Operating Expenses
144.3499.5786.263.2120.59
Upgrade
Operating Income
-282.77-237.21224.91204.41156.03
Upgrade
Interest Expense
-----6.81
Upgrade
Interest & Investment Income
38.4742.2516.083.330.29
Upgrade
Other Non Operating Income (Expenses)
11.213.18.2111.918.32
Upgrade
EBT Excluding Unusual Items
-233.1-181.86249.2219.65157.83
Upgrade
Gain (Loss) on Sale of Investments
17.43.9-1.7-0.5-
Upgrade
Asset Writedown
-32--8.4--
Upgrade
Other Unusual Items
47.33.93---
Upgrade
Pretax Income
-200.4-174.03239.1219.15157.83
Upgrade
Income Tax Expense
-37.54-27.6380.5865.6938.92
Upgrade
Net Income
-162.86-146.4158.52153.46118.92
Upgrade
Preferred Dividends & Other Adjustments
----33.82
Upgrade
Net Income to Common
-162.86-146.4158.52153.4685.1
Upgrade
Net Income Growth
--3.29%29.05%-
Upgrade
Shares Outstanding (Basic)
294289285276159
Upgrade
Shares Outstanding (Diluted)
294289315318263
Upgrade
Shares Change (YoY)
1.79%-8.15%-1.09%20.96%73.88%
Upgrade
EPS (Basic)
-0.55-0.510.560.560.53
Upgrade
EPS (Diluted)
-0.55-0.510.500.480.45
Upgrade
EPS Growth
--4.17%6.21%-
Upgrade
Free Cash Flow
-186.95-120.82206.7186.1313.02
Upgrade
Free Cash Flow Per Share
-0.64-0.420.660.580.05
Upgrade
Gross Margin
--64.09%71.33%75.75%
Upgrade
Operating Margin
-980.70%-623.82%46.33%54.48%66.92%
Upgrade
Profit Margin
-564.83%-385.00%32.66%40.90%36.50%
Upgrade
Free Cash Flow Margin
-648.40%-317.75%42.58%49.61%5.58%
Upgrade
EBITDA
-223.92-212.81244.35218.88160.87
Upgrade
EBITDA Margin
--50.34%58.34%69.00%
Upgrade
D&A For EBITDA
58.8524.419.4414.474.84
Upgrade
EBIT
-282.77-237.21224.91204.41156.03
Upgrade
EBIT Margin
--46.33%54.48%66.92%
Upgrade
Effective Tax Rate
--33.70%29.97%24.66%
Upgrade
Revenue as Reported
28.8338.03485.42375.2233.16
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q